Recent Episodes
Highlights from Attending ASH 2024
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL
Understanding Mental Health in Cancer Survivorship
Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN
What’s New in Chronic Lymphocytic Leukemia (CLL)?
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH
The Role of the Healthcare Team in Biomarker Testing
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT
Decoding Medicare for Healthcare Professionals
Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY
Categories
- All Episodes (92)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (31)
- Genomics (3)
- Health Equity (7)
- Leukemia (22)
- Lymphoma (13)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (12)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
